EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair

Valeria Magni, Marianna Adamo, Elisa Pezzola, Antonio Popolo Rubbio, Cristina Giannini, Giulia Masiero, Carmelo Grasso, Paolo Denti, Arturo Giordano, Federico De Marco, Antonio L Bartorelli, Matteo Montorfano und 20 weitere

Clinical Research in Cardiology · 2025

DOI: 10.1007/s00392-024-02490-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Valeria Magni und 31 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology and Cardiac Catheterization Laboratory, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Rad…. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Failure, Mitral Valve, Cardiac Catheterization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Brescia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To assess the interaction between heart failure (HF) severity and optimal reduction of secondary mitral regurgitation (SMR) on mortality in patients undergoing transcatheter edge-to-edge repair (M-TEER). Methods and results Among 1656 patients included in the Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO) 984 had SMR and complete data on advanced HF. Advanced HF was defined as NYHA class III or IV, left ventricular ejection fraction ≤ 30%, and > 1 HF hospitalization during the last 12 months. Optimal M-TEER was defined as residual SMR ≤ 1 + at discharge. One hundred sixteen patients (11.8%) had advanced HF. Achievement of an optimal SMR reduction was similar in patients with and without advanced HF (65% and 60% respectively). Advanced HF was an independent predictor of 2-year all-cause death (adjusted HR 1.52, 95% CI 1.09–2.10). Optimal M-TEER, as compared to a no-optimal M-TEER, was associated with a reduced risk of death both in patients with advanced (HR 0.55, 95% CI 0.32–0.97; p = 0.039) and no-advanced HF (HR 0.59, 95% CI 0.46–0.78; p < 0.001; p = 0.778 for interaction).

Conclusions

Advanced HF is associated with poor outcome in patients undergoing M-TEER. However, an optimal SMR reduction reduces the risk of 2-year mortality regardless of HF severity. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyHeart FailureMitral ValveCardiac CatheterizationHeart Valve Prosthesis ImplantationHumansMaleFemaleSeverity of Illness IndexRegistriesAgedItalyAged, 80 and overTreatment OutcomeStroke VolumeSurvival RateRisk FactorsVentricular Function, LeftFollow-Up StudiesTime FactorsCause of Death

Stichwörter der Autor:innen

Advanced heart failureMitral transcatheter edge-to-edge repairSecondary mitral regurgitation

Autor:innen und Institutionen

  • Division of Cardiology and Cardiac Catheterization Laboratory, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia,…
  • Division of Cardiology, Ospedale di Desenzano, Desenzano, Italy.
  • Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
  • Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
  • Interventional Cardiology Unit, Department of Cardiac, Thoracic and Vascular Science, University of Padua, Padua, Italy.
  • Division of Cardiology, Centro Alte Specialità e Trapianti (CAST), Azienda Ospedaliero-Universitaria Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy.

Förderung

  • Università degli Studi di Brescia

Zitieren

APA

Magni, V., Adamo, M., Pezzola, E., Rubbio, A. P., Giannini, C., Masiero, G., Grasso, C., Denti, P., Giordano, A., De Marco, F., Bartorelli, A. L., Montorfano, M., Godino, C., Baldi, C., De Felice, F., Mongiardo, A., Monteforte, I., Villa, E., Crimi, G., …, & Metra, M. (2025). Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02490-7

Vancouver

Magni V, Adamo M, Pezzola E, Rubbio AP, Giannini C, Masiero G, et al. Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-024-02490-7

BibTeX
@article{Magni2025,
  author = {Magni, Valeria and Adamo, Marianna and Pezzola, Elisa and Rubbio, Antonio Popolo and Giannini, Cristina and Masiero, Giulia and Grasso, Carmelo and Denti, Paolo and Giordano, Arturo and De Marco, Federico and Bartorelli, Antonio L and Montorfano, Matteo and Godino, Cosmo and Baldi, Cesare and De Felice, Francesco and Mongiardo, Annalisa and Monteforte, Ida and Villa, Emmanuel and Crimi, Gabriele and Tusa, Maurizio and Testa, Luca and Serafini, Lisa and Cani, Dario and Guarini, Giacinta and Huqi, Alda and Sesana, Marco and De Carlo, Marco and Maisano, Francesco and Tarantini, Giuseppe and Tamburino, Corrado and Bedogni, Francesco and Metra, Marco},
  title = {Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  doi = {10.1007/s00392-024-02490-7}
}
Kostenlos starten →